Roundtable: Aligning Procurement With FDA’s Non-Animal Testing Initiative to Advance Ethical & Efficient Pre-Clinical Research
- Partnering with R&D, regulatory, and supplier ecosystems to adopt validated in vitro and in silico alternatives
- Reassessing sourcing frameworks and supplier qualification to support non-animal testing technologies
- Learning from early adopters on balancing scientific rigor, regulatory acceptance, and operational feasibility